Safety of Insulin Lispro and a Biosimilar Insulin Lispro When Administered Through an Insulin Pump

BACKGROUND: SAR342434 (U100; SAR-Lis; insulin lispro) is a biosimilar/follow-on to insulin lispro (U100; Ly-Lis). Similar pharmacokinetics/pharmacodynamics between the two products has been demonstrated in a hyperinsulinemic euglycemic clamp study. The current study evaluated the safety of SAR-Lis a...

Descripción completa

Detalles Bibliográficos
Autores principales: Thrasher, James, Surks, Howard, Nowotny, Irene, Pierre, Suzanne, Rotthaeuser, Baerbel, Wernicke-Panten, Karin, Garg, Satish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154226/
https://www.ncbi.nlm.nih.gov/pubmed/29359575
http://dx.doi.org/10.1177/1932296817753644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154226/
https://www.ncbi.nlm.nih.gov/pubmed/29359575
http://dx.doi.org/10.1177/1932296817753644

Ejemplares similares